GRIDX

www.gridexponential.com

GRIDX helps transform bioscience knowledge and talent in Latin America into global-impact startups that will define the bioeconomy. They focus on four domain areas: Agri-food-land use, Bio-Industry, Deep-biotech, and Human health, seeking companies that replace non-life-compatible systems with sustainable alternatives.

Check Size

Not specified

Stages

Pre Seed, Seed

Focus Areas

Biotech, Agtech, Healthtech

Is GRIDX right for your startup?

Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.

See If You're a Match

Investment Thesis

Grid Exponential operates on the belief that we are entering the ‘Life-Based Age’ where biology, digital tools, and advanced engineering will fundamentally reshape how we produce food, materials, and energy, and deliver breakthrough therapies. They describe this as a civilizational necessity and ‘once-in-a-generation economic and strategic opportunity.’ Their philosophy centers on transforming the extractive, fossil-based industrial paradigm into life-compatible production systems aligned with living systems’ dynamics, addressing both human and planetary health.

What Sets Them Apart

Regional venture builder model based in Latin America with on-the-ground teams across 8 countries
Unique three-stage TRANSFORM program (IGNITE, BUILD, JOURNEY TO FUNDRAISING) designed to nurture science-based startups from concept to fundraising-ready
Hands-on approach: 'our own team of scientists and business professionals works hands-on with you throughout the journey'
Proprietary deep-science mapping initiative covering 6000+ projects across 7 countries and 250+ institutions
Interdisciplinary team formation: systematically pairs scientists with business co-founders to create complementary founding teams
Cost and talent arbitrage: 'Scientific capacity in the region comes at a fraction of the cost—roughly one-tenth of R&D budgets in developed markets'
Ecosystem access: largest innovation ecosystem in LATAM with 250+ founders and 1000+ bioprofessionals
Proven track record: 90+ funded startups, 70% of one-year-since-release companies re-invested by worldwide funds, $115MM follow-on capital raised